Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 116

1.

The impact of computed radiography and teleradiology on patients' diagnosis and treatment in Mweso, the Democratic Republic of Congo.

Crumley I, Halton J, Greig J, Kahunga L, Mwanga JP, Chua A, Kosack C.

PLoS One. 2020 Jan 15;15(1):e0227773. doi: 10.1371/journal.pone.0227773. eCollection 2020.

2.

Preparedness for emerging epidemic threats: a Lancet Infectious Diseases Commission.

Lee VJ, Aguilera X, Heymann D, Wilder-Smith A; Lancet Infectious Diseases Commission.

Lancet Infect Dis. 2020 Jan;20(1):17-19. doi: 10.1016/S1473-3099(19)30674-7. No abstract available.

PMID:
31876487
3.

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children.

Brandao LR, Albisetti M, Halton J, Bomgaars L, Chalmers E, Mitchell LG, Nurmeev I, Svirin P, Kuhn T, Zapletal O, Tartakovsky I, Simetzberger M, Huang F, Sun Z, Kreuzer J, Gropper S, Brueckmann M, Luciani M.

Blood. 2019 Dec 5. pii: blood.2019000998. doi: 10.1182/blood.2019000998. [Epub ahead of print]

4.

The Accuracy of Prevalent Vertebral Fracture Detection in Children Using Targeted Case-Finding Approaches.

Ma J, Siminoski K, Wang P, Alos N, Cummings EA, Feber J, Halton J, Ho J, Houghton K, Lang B, Miettunen PM, Scuccimarri R, Jaremko JL, Koujok K, Lentle B, Matzinger MA, Shenouda N, Rauch F, Ward LM; and the Canadian Steroid-Induced Osteoporosis in the Pediatric Population (STOPP) Consortium.

J Bone Miner Res. 2019 Nov 19. doi: 10.1002/jbmr.3922. [Epub ahead of print]

PMID:
31742768
5.

Bodyweight-adjusted rivaroxaban for children with venous thromboembolism (EINSTEIN-Jr): results from three multicentre, single-arm, phase 2 studies.

Monagle P, Lensing AWA, Thelen K, Martinelli I, Male C, Santamaría A, Samochatova E, Kumar R, Holzhauer S, Saracco P, Simioni P, Robertson J, Grangl G, Halton J, Connor P, Young G, Molinari AC, Nowak-Göttl U, Kenet G, Kapsa S, Willmann S, Pap AF, Becka M, Twomey T, Beyer-Westendorf J, Prins MH, Kubitza D; EINSTEIN-Jr Phase 2 Investigators.

Lancet Haematol. 2019 Oct;6(10):e500-e509. doi: 10.1016/S2352-3026(19)30161-9. Epub 2019 Aug 13.

PMID:
31420317
6.

Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study.

Pelland-Marcotte MC, Tucker C, Klaassen A, Avila ML, Amid A, Amiri N, Williams S, Halton J, Brandão LR.

Lancet Haematol. 2019 Mar;6(3):e144-e153. doi: 10.1016/S2352-3026(18)30224-2. Epub 2019 Feb 13.

PMID:
30772417
7.

Clinical presentation and therapeutic management of venous thrombosis in young children: a retrospective analysis.

Chan A, Lensing AWA, Kubitza D, Brown G, Elorza D, Ybarra M, Halton J, Grunt S, Kenet G, Bonnet D, Santamaria A, Saracco P, Biss T, Climent F, Connor P, Palumbo J, Thelen K, Smith WT, Mason A, Adalbo I, Berkowitz SD, Hurst E, van Kesteren J, Young G, Monagle P.

Thromb J. 2018 Nov 1;16:29. doi: 10.1186/s12959-018-0182-4. eCollection 2018.

8.

Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.

Ma J, Siminoski K, Alos N, Halton J, Ho J, Cummings EA, Shenouda N, Matzinger MA, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis VA, Laverdière C, Israels S, Grant RM, Fernandez CV, Dix DB, Couch R, Cairney E, Barr R, Atkinson S, Abish S, Moher D, Rauch F, Ward LM; Canadian STOPP Consortium.

J Clin Endocrinol Metab. 2019 Feb 1;104(2):213-222. doi: 10.1210/jc.2018-01083.

9.

Anticoagulant Effects of Dabigatran in Paediatric Patients Compared with Adults: Combined Data from Three Paediatric Clinical Trials.

Maas H, Gropper S, Huang F, Stangier J, Tartakovsky I, Brueckmann M, Halton JML, Mitchell LG.

Thromb Haemost. 2018 Sep;118(9):1625-1636. doi: 10.1055/s-0038-1668132. Epub 2018 Aug 15.

10.

Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design.

Luciani M, Albisetti M, Biss B, Bomgaars L, Brueckmann M, Chalmers E, Gropper S, Halton JML, Harper R, Huang F, Manastirski I, Mitchell LG, Tartakovsky I, Wang B, Brandão LR.

Res Pract Thromb Haemost. 2018 Apr 24;2(3):580-590. doi: 10.1002/rth2.12093. eCollection 2018 Jul.

11.

Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism.

Albisetti M, Biss B, Bomgaars L, Brandão LR, Brueckmann M, Chalmers E, Gropper S, Harper R, Huang F, Luciani M, Manastirski I, Mitchell LG, Tartakovsky I, Wang B, Halton JML.

Res Pract Thromb Haemost. 2018 Mar 25;2(2):347-356. doi: 10.1002/rth2.12086. eCollection 2018 Apr.

12.

Bone Morbidity and Recovery in Children With Acute Lymphoblastic Leukemia: Results of a Six-Year Prospective Cohort Study.

Ward LM, Ma J, Lang B, Ho J, Alos N, Matzinger MA, Shenouda N, Lentle B, Jaremko JL, Wilson B, Stephure D, Stein R, Sbrocchi AM, Rodd C, Lewis V, Israels S, Grant RM, Fernandez CV, Dix DB, Cummings EA, Couch R, Cairney E, Barr R, Abish S, Atkinson SA, Hay J, Rauch F, Moher D, Siminoski K, Halton J; Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium.

J Bone Miner Res. 2018 Aug;33(8):1435-1443. doi: 10.1002/jbmr.3447. Epub 2018 May 22.

13.

Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism.

Halton JML, Picard AC, Harper R, Huang F, Brueckmann M, Gropper S, Maas H, Tartakovsky I, Nurmeev I, Mitchell LG, Brandão LR, Chalmers E, Albisetti M.

Thromb Haemost. 2017 Nov;117(11):2168-2175. doi: 10.1160/TH17-06-0429. Epub 2017 Nov 30.

PMID:
29202215
14.

Guidelines for the use of chest radiographs in community-acquired pneumonia in children and adolescents.

Andronikou S, Lambert E, Halton J, Hilder L, Crumley I, Lyttle MD, Kosack C.

Pediatr Radiol. 2017 Oct;47(11):1405-1411. doi: 10.1007/s00247-017-3944-4. Epub 2017 Sep 21. Review.

15.

Phase IIa study of dabigatran etexilate in children with venous thrombosis: pharmacokinetics, safety, and tolerability.

Halton JML, Albisetti M, Biss B, Bomgaars L, Brueckmann M, Gropper S, Harper R, Huang F, Luciani M, Maas H, Tartakovsky I, Mitchell LG.

J Thromb Haemost. 2017 Nov;15(11):2147-2157. doi: 10.1111/jth.13847. Epub 2017 Oct 26.

16.

Evaluation of a chest radiograph reading and recording system for tuberculosis in a HIV-positive cohort.

Kosack CS, Spijker S, Halton J, Bonnet M, Nicholas S, Chetcuti K, Mesic A, Brant WE, Joekes E, Andronikou S.

Clin Radiol. 2017 Jun;72(6):519.e1-519.e9. doi: 10.1016/j.crad.2017.01.008. Epub 2017 Feb 21.

17.

Pediatric Oncology Clinic Care Model: Achieving Better Continuity of Care for Patients in a Medium-sized Program.

Johnston DL, Halton J, Bassal M, Klaassen RJ, Mandel K, Ramphal R, Simpson E, Peckan L.

J Pediatr Hematol Oncol. 2017 Aug;39(6):476-480. doi: 10.1097/MPH.0000000000000689.

PMID:
27782926
18.

Safety, tolerability and clinical pharmacology of dabigatran etexilate in adolescents. An open-label phase IIa study.

Halton JM, Lehr T, Cronin L, Lobmeyer MT, Haertter S, Belletrutti M, Mitchell LG.

Thromb Haemost. 2016 Aug 30;116(3):461-71. doi: 10.1160/TH15-04-0275. Epub 2016 Jun 30.

PMID:
27357738
19.

Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: A risk model.

Spavor M, Halton J, Dietrich K, Israels S, Shereck E, Yong J, Yasui Y, Mitchell LG.

Thromb Res. 2016 Aug;144:27-31. doi: 10.1016/j.thromres.2016.05.015. Epub 2016 May 18.

PMID:
27270219
20.

The Spectrum of Recovery From Fracture-Induced Vertebral Deformity in Pediatric Leukemia.

Dal Osto LC, Konji VN, Halton J, Matzinger MA, Bassal M, Rauch F, Ward LM.

Pediatr Blood Cancer. 2016 Jun;63(6):1107-10. doi: 10.1002/pbc.25942. Epub 2016 Feb 15.

PMID:
26878592

Supplemental Content

Loading ...
Support Center